Lipid vesicles and other colloids as drug carriers on the skin

Advanced Drug Delivery Reviews

Volumn 56, Issue 5, 2004, Pages 675-711

  Cevc, Gregor ^a  

^a IDEA AG   (Germany)

Author keywords

Emulsions; Epicutaneous phase behaviour; Pore density; Pores; Transcutaneous hydrophilic pathways; Transferosomes; Ultradeformable vesicles

Indexed keywords

BLOOD; CELL MEMBRANES; COLLOIDS; ELASTICITY; HYDROPHILICITY; LIPIDS; ORGANIC SOLVENTS; SKIN; SUSPENSIONS (FLUIDS);

COLLOID ADAPATABILITY; LIPID VESICLES;

DRUG PRODUCTS;

ALPHA INTERFERON; CALCITONIN; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DICLOFENAC; DOLAUT; DRUG ADDITIVE; DRUG CARRIER; ECONAZOLE; ESTRADIOL; GAMMA INTERFERON; GLUCOCORTICOID; HEPAPLUS; HEPARIN; HYDROCORTISONE; IBUPROFEN; INSULIN; LIDOCAINE; LIPOSOME; NANOPARTICLE; NEUTRAL INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENETRATION ENHANCING AGENT; RECOMBINANT ALPHA2B INTERFERON; TAMOXIFEN; TESTOSTERONE; TETRACAINE; TRANSFERSOMES; TRIAMCINOLONE ACETONIDE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER;

BILAYER MEMBRANE; CHANNEL GATING; CHROMATOGRAPHY; COLLOID; CREAM; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUTION; DRUG TARGETING; DRUG TRANSPORT; ELASTICITY; HUMAN; HYDROPHILICITY; LIPID COMPOSITION; LIPID VESICLE; MICELLE; NONHUMAN; OINTMENT; PRIORITY JOURNAL; REVIEW; SKIN; SKIN CELL; SKIN SURFACE; SUSTAINED DRUG RELEASE;

EID: 1542268930     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.028     Document Type: Article

References (232)

1. Shah V.P., Flynn G.L., Yacobi A., Maibach H.I., Bon C., Fleischer N.M., Franz T.J., Kaplan S.A., Kawamoto J., Lesko L.J., Marty J.P., Pershing L.K., Schaefer H., Sequeira J.A., Shrivastava S.P., Wilkin J., Williams R.L. Bioequivalence of topical dermatological dosage forms - methods of evaluation of bioequivalence. Skin Pharmacol. Appl. Skin Physiol. 11:1998;117-124.
2. Smith E.W., Maibach H.I. Percutaneous Penetration Enhancers. 1995;CRS Press, New York.
3. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol. Appl. Skin Physiol. 14:2001;72-81.
4. Henry S., McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87:1998;922-925.
5. Machet L., Boucaud A. Phonophoresis: efficiency, mechanisms and skin tolerance. Int. J. Pharm. 243:2002;1.
6. Banga A.K., Prausnitz M.R. Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. TIBTECH. 16:1998;408-412.
7. J. Eppstein, A. Smith, T. Woods, M. McRae, M. Hatch, J. Papp, J. Connolly, H. Delcher, Transdermal insulin infusion via thermal micropores with the MicroPor™ universal drug delivery system, CRS Poster Session III/8025, 2000.
8. Cevc G., Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta. 1104:1992;226-232.
9. Cevc G., Schätzlein A., Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release. 36:1995;3-16.
10. Hadgraft J. Skin, the final frontier. Int. J. Pharm. 224:2001;1-18.
11. Christophers E., Schubert C., Goos M. The epidermis. Greaves M.W., Shuster S. Pharmacology of the Skin. 1989;Springer, Berlin.
12. Fartasch M. The nature of the epidermal barrier: structural aspects. Adv. Drug Deliv. Rev. 18:1996;273-282.
13. Schurer N.Y., Plewig G., Elias P.M. Stratum corneum lipid function. Dermatologica. 183:1991;77-94.
14. Schätzlein A., Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138:1998;583-592.
15. Wertz P.W., Downing D.T. Stratum corneum: biological and biochemical considerations. Hadgraft J., Guy R.H. Transdermal Drug Delivery: Developmental Issues and Research Initatives. 1989;1-22 Marcel Dekker, New York.
16. Elias P.M. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism. J. Control. Release. 15:1991;199-208.
17. Hadgraft J., Walters K.A., Guy R.H. Epidermal lipids and topical drug delivery. Semin. Dermatol. 11:1992;139-144.
18. Sheu H.M., Lee J.Y., Chai C.Y., Kuo K.W. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br. J. Dermatol. 136:1997;884-890.
19. Charalambopoulou G.C., Karamertzanis P., Kikkinides E.S., Stubos A.K., Kanellopoulos N.K., Papaioannou A.T. A study on structural and diffusion properties of porcine stratum corneum based on very small angle neutron scattering data. Pharm. Res. 17:2000;1085-1091.
20. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669.
21. Moss G.P., Dearden J.C., Patel H., Cronin M.T.D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. Vitro. 16:2002;299-317.
22. Patel H., ten Berge W., Cronin M.T.D. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere. 48:2002;603-613.
23. Forslind B. The skin barrier: analysis of physiologically important elements and trace elements. Acta Dermatovenereol. Suppl. (Stockholm). 208:2000;46-52.
24. Schaefer P., Bewick-Sonntag C., Capri M.G., Berardesca E. Physiological changes in skin barrier function. Skin Pharmacol. Appl. Skin Physiol. 15:2002;7-19.
25. Hsieh D.S. Drug Permeation Enhancement, Theory and Applications. 1993;Marcel Dekker, New York.
26. Hadgraft J., Pugh W.J. The selection and design of topical and transdermal agents: a review. J. Invest. Dermatol. (Symp. Proc.). 3:1998;131-135.
27. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17:2000;1354-1359.
28. Cevc G. Drug delivery across the skin. Exp. Opin. Invest. Drugs. 6:1997;1887-1937.
29. Schmook F.P., Meingassner J.G., Billich A. Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. Int. J. Pharm. 215:2001;51-56.
30. Kreuter J. Colloidal Drug Delivery Systems. 1994;Marcel Dekker, New York.
31. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;257-388.
32. Cevc G. Phospholipids Handbook. 1993;Marcel Dekker, New York.
33. Almgren M. Mixed micelles and other structures in the solubilization ob bilayer lipid membranes by surfactant. Biochim. Biophys. Acta. 1508:2000;146-163.
34. Heerklotz H., Seelig J. Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. Biophys. J. 78:2000;2435-2440.
35. Kozlov M.M., Opatowski E., Lichtenberg D. Calorimetric studies of the interactions between micelle-forming and bilayer-forming amphiphiles. J. Thermal Anal. 51:1998;173-189.
36. Touitou E., Junginger H.E., Weiner N.D., Nagai T., Mezei M. Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci. 83:1994;1189-1203.
37. Schreier H., Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control. Release. 30:1994;1-15.
38. Schaller M., Korting H.C. Interaction of liposomes with human skin: the role of the stratum. Adv. Drug Deliv. Rev. 18:1996;303-309.
39. Cevc G. Overcoming the skin barrier with artificial smart carriers of drugs. Dinh S.M., DeNuzzio J., Comfort A.R. Intelligent Materials for Controlled Release Technologies. 1999;70-86 ACS Books, Washington, DC.
40. Betz G., Imboden R., Imanidis G. Interaction of liposome formulations with human skin in vitro. Int. J. Pharm. 229:2001;117-129.
41. Paolino D., Ventura C.A., Nistico S., Puglisi G., Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int. J. Pharm. 244:2002;21-31.
42. Krstic R.V. Die Gewebe des Menschen und der Saeugetiere. 1988;23 Springer, Berlin.
43. Hajime I. Epidermal turnover time. J. Dermatol. Sci. 8:1994;215-217.
44. Pirot F., Kalia Y.N., Berardesca E., Singh M., Maibach H.I., Guy R.H. Stratum corneum thickness and apparent water diffusivity: facile and noninvasive quantitation in vivo. Pharm. Res. 15:1998;490-492.
45. Steinstraesser I., Merkle H.P. Dermal metabolism of topically applied drugs: pathways and models reconsidered. Pharm. Acta Helv. 70:1995;3-24.
46. Boderke P., Schittkowski K., Wolf M., Merkle H.P. Modeling of diffusion and concurrent metabolism in cutaneous tissue. J. Theor. Biol. 204:2000;393-407.
47. Salmon J.K., Armstrong C.A., Ansel J.C. The skin as an immune organ. West. J. Med. 160:1994;146-152.
48. Williams I.R., Kupper T.S. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 58:1996;1485-1507.
49. Plewig G., Scheuber E., Reuter B., Waidelich W. Thickness of corneocytes in stratum corneum. Stratum Corneum. 1983;171-174 Springer, Berlin.
50. Johnson M., Blankschtein D., Langer R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 86:1997;1162-1172.
51. Mackenzie ICK Z., Peterson L. The pattern of cellular organization of human epidermis. J. Invest. Dermatol. 76:1981;459-461.
52. P.S. Talreja, G.B. Kasting, N.K. Kleene, W.L. Pickens, T.-F. Wang, Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum, AAPS Pharm. Sci. 3 (2001) (Article 13) (an internet publication).
53. Fesq H H.P., Richardsen H., Cevc G., Ring J., Abeck D. Detection of transdermal intercluster gaps in human epidermis with the help of highly deformable lipid vesicles (Transfersomes®) and confocal laser scanning microscopy. Arch. Derm. Res. 291:1999;130.
54. Fartasch M., Bassukas I.D., Diepgen T.L. Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br. J. Dermatol. 128:1993;1-9.
55. DoucetO G.N., Rosdy M., Fartasch M., Zastrow L. Critical events in the barrier development of reconstructed epidermis. Perspect. Percutaneous Penetration. 5:1997;141-144.
56. Fartasch M., Bassukas I.D., Diepgen T.L. Structural relationship between epidermal lipid lamellae, lammelar bodies and desmosomes in human epidermis: an ultrastructural study. Br. J. Dermatol. 128:1993;1-9.
57. Ponec M., Boelsma E., Weerheim A., Mulder A., Bouwstra J., Mommaas M. Lipid and ultrastructural characterization of reconstructed skin models. Int. J. Pharm. 203:2000;211-225.
58. Wertz W., Downing D.T. Covalently bound w-hydroxyacylsphingosine in the stratum corneum. Biochim. Biophys. Acta. 917:1987;108-111.
59. Swartzendruber D.C., Wertz P.W., Madison K.C., Downing D.T. Evidence that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol. 88:1987;709-713.
60. Man M.M.Q., Feingold K.R., Thornfeldt C.R., Elias P.M. Optimization of physiological lipid mixture for barrier repair. J. Inv. Dermatol. 106:1996;1096-1101.
61. Surber C., Wilhelm K.P., Hori M., Maibach H.I., Guy R.H. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm. Res. 7:1990;1320-1324.
62. Yoshida N.H., Roberts M.S. Solute molecular size and transdermal iontophoresis across excised human skin. J. Control. Release. 25:1993;177-195.
63. Barratt M.D. Quantitative structure-activity relationships for skin permeability. Toxicol. Vitro. 9:1995;27-37.
64. Cronin M.T.D., Dearden J.C., Moss G.P., Murray-Dickson G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur. J. Pharm. Sci. 7:1999;325-330.
65. Benita S.E., Submicron Emulsions in Drug Targeting and Delivery. 1998;Harwood Academic Publishers, Chur.
66. Potts R.O., Guy R.H., Francoeur M.L. Lipid biophysics of water loss through the skin. Proc. Natl. Acad. Sci. USA. 87:1990;3871-3873.
67. R.R. Warner, N.A. Lilly, Correlation of water content with ultrastructure in the stratum corneum, Bioengineering of the skin. Water and the stratum corneum. CRC Press, Boca Raton, FL.
68. Cevc G. Drug delivery across the skin. Exp. Opin. Invest. Drugs. 6:1997;1887-1937.
69. Banga A.K., Bose S., Ghosh T.K. Iontophoresis and electroporation: comparisons and contrasts. Int. J. Pharm. 179:1999;1-19.
70. Panchagnular R., Pillai O., Nair V.B., Ramarao P. Transdermal iontophoresis revisited. Curr. Opin. Chem. Biol. 4:2000;468-473.
71. Byl N.N. The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis. Phys. Ther. 75:1995;539-553.
72. Kost J. Ultrasound and transdermal transport for drug delivery and diagnostics. Pharma Tech. 2001;196-202.
73. Tezel A., Sens A., Mitragotri S. A theoretical analysis of low-frequency sonophoresis: dependence of transdermal transport pathways on frequency and energy density. Pharm. Res. 19:2002;1841-1846.
74. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
75. Degano S., Sarphie D.F., Bangham C.R.M. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect® system. Vaccine. 16:1998;394-398.
76. Burkoth T.L., Bellhouse B.J., Hewson G., Longridge D.J., Muddle A.G., Sarphie D.F. Transdermal and transmucosal powdered drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 16:1999;331-384.
77. Fan H., Lin Q., Morrissey G.R., Khavari P.A. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. 17:1999;870-872.
78. J. Lademann, H. Richter, H.J. Weigmann, U. Lindemann, H. Schaefer, W. Sterry, Transfollicular absorption, J. Eur. Acad. Dermatovenereol. 15 (Suppl. 2) (2001) 28.
79. L. Li, V. Lishko, L. Margolis, V.K.R. Hoffman, Product-delivering liposomes specifically target hair follicles in histocultured intact skin (letter), In Vitro Cell Dev. Biol. 28A (1992) 679-681.
80. Lauer A.C., Lieb L.M., Ramachandran C., Flynn G., Weiner N.D. Transfollicular drug delivery. Pharm. Res. 12:1995;179-186.
81. Niemiec S.M., Ramachandran C., Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. Pharm. Res. 12:1995;1184-1188.
82. Li L., Hoffman R.M. Topical liposome delivery of molecules to hair follicles in mice. J. Dermatol. Sci. 14:1997;101-108.
83. Aguilella V., Kontturi K., Murtomäki L., Ramirez P. Estimation of the pore size and charge density in human cadaver skin. J. Control. Release. 32:1994;249-257.
84. Pikal M.J. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm. Res. 7:1990;118-126.
85. Ruddy S.B., Hadzija B.W. Iontophoretic permeability of polyethylene glycols through hairless rat skin: application of hydrodynamic theory for hindered transport through liquid-filled pores. Drug Des. Discov. 8:1992;207-224.
86. Cevc G. Transfersomes®, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;257-388.
87. Schätzlein A., Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138:1998;583-592.
88. Kontturi K., Murtomaeki L. Mechanistic model for transdermal transport including iontophoresis. J. Control. Release. 41:1996;177-185.
89. Kadir R., Tiemessen H.L.G.M., Ponec M., Junginger H.E., Bodde H.E. Oleyl surfactants as skin penetration enhancers. Effects on human stratum corneum permeability and in vitro toxicity to cultured human skin cells. Walters K., Hadgraft J. Pharmaceutical Skin Penetration Enhancement. 1993;215-227 Marcel Dekker, New York.
90. van den Bergh B.A.I., Vroom J., Gerritsen H., Junginger H.E., Bouwstra J.A. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy. Biochim. Biophys. Acta. 1461:1999;155-173.
91. Schaefer P., Bewick-Sonntag C., Capri M.G., Berardesca E. Physiological changes in skin barrier function in relation to occlusion level, exposure time and climatic conditions. Skin Pharmacol. Appl. Skin Physiol. 15:2002;7-19.
92. Zhai H., Maibach H.I. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 14:2001;1-10.
93. Rawlings A.V., Scott I.R., Harding C.R., Bowser P.A. Stratum corneum moisturization at the molecular level. J. Invest. Dermatol. 103:1994;731-740.
94. Kleman M., Lavrentovich O.D. Order and Disorder in Soft Matter Physics. 2002;Springer, Heidelberg.
95. Cevc G., Seddon J.M. Lipid polymorphism. Cevc G. Phospholipid Handbook. vol. 1:1993;403-454 Marcel Dekker, New York.
96. Cevc G. Hydration force and the interfacial structure of the polar surface. J. Chem. Soc. Faraday Trans. 87:1991;2733-2739.
97. Cevc G., Hauser M., Kornyshev A.A. Effects of the interfacial structure on the hydration force between laterally non-uniform surfaces. Langmuir. 11:1995;3103-3110.
98. Evans E., Rawicz W. Elasticity of "Fuzzy" biomembranes. Phys. Rev. Lett. 79:1997;2379-2382.
99. Cevc G. Colloidal and phase behaviour of biomacromolecules interdepend and are regulated by the supramolecular surface polarity. Examples with lipid bilayer membranes. J. Physique. 50:1989;1117-1134.
100. Cowley A.C., Fuller N.L., Rand R.P., Parsegian V.A. Measurement of repulsive forces between charged phospholipid bilayers. Biochemistry. 17:1978;3163-3168.
101. Evans E.A., Parsegian V.A. Thermal-mechanical fluctuations enhance repulsion between biomolecular layers. Proc. Natl. Acad. Sci. USA. 83:1986;7132-7136.
102. Mak V.H.W., Potts R.O., Guy R.H. Does hydration affect intercellular lipid organization in the stratum corneum? Pharm. Res. 8:1991;1064-1065.
103. Helfrich W. Size distributions of vesicles: the role of the effective rigidity of membranes. J. Physique. 47:1986;321-329.
104. Larrabee A.L. Time-dependent changes in the size distribution of distearoylphosphatidylcholine vesicles. Biochemistry. 18:1979;3321-3326.
105. Müller R.H., Dingler A. The next generation after the liposomes: solid lipid nano particles (SLN®, LipopearlsTM) as dermal carrier in cosmetics. Eurocosmetics. 7/8:1998;19-26.
106. Westesen K B.H., Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release. 48:1997;223-236.
107. Gelbart W.M., Ben-Shaul A., Roux D. Micelles, Membranes, Microemulsions and Monolayers. 1994;Springer, Berlin.
108. R.L. Scartazzini, P.L. Luisi, Organogels from lecithins, J. Phys. Chem. 92 (1988) 829-833.
109. P.L. Luisi, R. Scartazzini, G. Haering, P. Schurtenberger, Organogels from water-in-oil microemulsions, Colloid Polym. Sci. 268 (1990) 356-374.
110. Berner B., Mazzenga G.C., Otte J.H., Steffens R.J., Juang R.H., Ebert C.D. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J. Pharm. Sci. 78:1989;402.
111. Vierl U., Lobbecke L., Nagel N., Cevc G. Solute effects on the colloidal and phase behavior of lipid bilayer membranes: ethanol- dipalmitoylphosphatidylcholine mixtures. Biophys. J. 67:1994;1067-1079.
112. L. Loebbecke, Calorimetric and fluorescence-spectroscopic investigations of interdigitated lipid phases (in German), Ph.D. Thesis, The Technical University of Munich, 1995.
113. Loebbecke L.L., Cevc G. Effects of short-chain alcohols on the phase behavior and interdigitation of phosphatidylcholine bilayer membranes. Biochim. Biophys. Acta. 1237:1995;59-69.
114. Lasch J. Interaction of detergents with lipid vesicles. Biochim. Biophys. Acta. 1241:1995;269-292.
115. Cevc G. Isothermal lipid phase transitions. Chem. Phys. Lipids. 57:1991;293-307.
116. Safinya C.R., Sirota E.B., Roux D., Smith G.S. Universality in interacting membranes: the effect of cosurfactants on the interfacial rigidity. Phys. Rev. Lett. 62:1989;1134-1137.
117. Chen Z., Rand R.P. The influence of cholesterol on phospholipid membrane curvature and bending elasticity. Biophys. J. 73:1997;267-276.
118. Olsson U., Bagger-Jorgensen H., Leaver M., Morris J., Mortensen K., Strey R., Schurtenberger P., Wennerstrom H. Stable, metastable and unstable oil-in-water droplets. Prog. Colloid Polym. Sci. 106:1997;6-13.
119. Jahn W., Strey R. Microstructure of microemulsions by freeze fracture microscopy. J. Phys. Chem. 92:1988;2294-2301.
120. Gompper G., Endo H., Mihailescu M., Allgaier J., Monkenbusch M., Richter D., Jakobs B., Sottmann T., Strey R. Measuring bending rigidity and spatial renormalization in bicontinuous microemulsions. Europhys. Lett. 56:2001;683-689.
121. Schmalfuß U., Neubert R., Wohlrab W. Modification of drug penetration into human skin using microemulsions. J. Control. Release. 46:1997;279-285.
122. Davis A.F., Hadgraft J. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int. J. Pharm. 76:1991;1-8.
123. Pellett M.A., Castellano S., Hadgraft J., Davis A.F. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Release. 46:1997;205-214.
124. Gompper G., Kroll D.M. Driven transport of fluid vesicles through narrow pores. Phys. Rev. E. 52:1995;4198-4208.
125. Bukman D.J., Yao J.H., Wortis M. Stability of cylindrical vesicles under axial tension. Phys. Rev. E. 54:1996;5463-5468.
126. Cevc G., Schätzlein A., Richardsen H., Vierl U. Overcoming semi-permeable barriers, such as the skin, with ultradeformable mixed lipid vesicles, Transfersomes®, liposomes or mixed lipid micelles. Langmuir. 19:2003;10753-10763.
127. Needham D., Evans E. Structure and mechanical properties of giant lipid (DMPC) vesicle bilayers from 20 below to 10 °C above the liquid-crystalline phase transition at 24 °C. Biochemistry. 27:1988;8261-8269.
128. Cevc G., Gebauer D. Hydration driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys. J. 84:2003;1010-1024.
129. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;257-388.
130. Van den Bergh B.A.I., Bouwstra J.A., Junginger H.E., Wertz P.W. Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control. Release. 62:1999;367-379.
131. D. Gabbier, Physicochemical studies of ultraflexible lipid vesicles (Transfersomes) (in German), Ph.D. Thesis, The Technical University of Munich, 1998.
132. Vutla N.B., Betageri G.V., Banga A.K. Transdermal iontophoretic delivery of enkephalin formulated in liposomes. J. Pharm. Sci. 85:1996;5-8.
133. Essa E.A., Bonner M.C., Barry B.W. Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int. J. Pharm. 240:2002;55-66.
134. Li G.L., Danhof M., Bouwstra J.A. Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro. Pharm. Res. 18:2001;1627-1630.
135. Bommannan D., Potts R.O., Guy R.H. Examination of the effect of ethanol on human straum corneum in vivo using infrared spectroscopy. J. Control. Release. 16:1991;299-304.
136. Schubert R., Joos M., Deicher M., Magerle R., Lasch J. Destabilization of egg lecithin liposomes on the skin after topical application measured by perturbed gamma gamma angular correlation spectroscopy (PAC) with 111In. Biochim. Biophys. Acta. 1150:1993;162-164.
137. Junginger H.E., Hofland H.E.J., Bouwstra J.A. Liposomes and niosomes: interactions with human skin. Cosmet. Toiletries. 106:1991;45-50.
138. Zellmer S., Pfeil W., Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim. Biophys. Acta. 1237:1995;176-182.
139. Hofland H.E.J., Bouwstra J.A., Bodde H.E., Spies F., Junginger H.E. Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br. J. Dermatol. 132:1995;853-856.
140. Lasch J., Bouwstra J. Interactions of external lipids (lipid vesicles) with the skin. J. Liposome Res. 5:1995;543-569.
141. Kirjavainen M., Urtti A., Jaaskelainen I., Suhonen T.M., Paronen P., Valjakka-Koskela R., Kiesvaara J., Monkkonen J. Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure. Biochim. Biophys. Acta. 1304:1996;179-189.
142. Bouwstra J.A., Hofland H.E.J., Spies F., Gooris G.S., Junginger H.E. Changes in the structure of the human stratum corneum induced by liposomes. Braun-Falco O., Kortung H.C., Maybach H.I. Liposome Dermatics. 1992;121-136 Springer, Berlin.
143. Lasch J., Zellmer S., Pfeil W., Schubert R. Interactions of liposomes with the human skin lipid barrier: hSCLLs as model system-DSC of intact stratum corneum and in situ of human skin. J. Liposome Res. 5:1995;99-108.
144. Zellmer S., Reissig D., Lasch J. Reconstructed human skin as model for liposome-skin interaction. J. Control. Release. 55:1998;271-279.
145. Jia-You Fang C.-T.H., Chiu W.-T., Wang Y.-Y. Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. 219:2001;61-72.
146. El Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. 53:2001;1069-1077.
147. El Maghraby G.M., Williams A.C., Barry B.W. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 196:2000;63-74.
148. Touitou E., Godin B., Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev. Res. 50:2000;406-415.
149. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release. 65:2000;403-418.
150. Dayan N., Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 21:2000;1879-1885.
151. E. Essa, M. Bonner, V. Barry, Passive and iontophoretic skin delivery of estradiol from ultradeformable liposomes, British Pharmaceutical Conference 2001, p. 62.
152. Cevc G., Gebauer D., Stieber J., Schätzlein A., Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta. 1368:1998;201-215.
153. M.E.M.J. van Kuijk-Meuwissen, H.E. Junginger, J.A. Bouwstra, Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study, J. Control. Release 56 (1998) 189-196.
154. Cevc G., Schatzlein A., Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta. 1564:2002;21-30.
155. du Plessis J W.N., Müller D.G. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro. Int. J. Pharm. 103:1994;R1-R5.
156. Pierre M.B., Tedesco A.C., Marchetti J.M., Bentley M.V. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 1:2001;5.
157. Fresta M., Puglisi G. Corticosteroid dermal delivery with skin-lipid liposomes. J. Control. Release. 44:1997;141-151.
158. Sarpotdar P.P., Zatz J.L. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro. J. Pharm. Sci. 75:1986;176-181.
159. Walters K.A., Walker M., Olejnik O. Non-ionic surfactant effects on hairless mouse skin permeability characteristics. J. Pharm. Pharmacol. 40:1988;525-529.
160. Hofland H.E.J., Vandergeest R., Bodde H.E., Junginger H.E., Bouwstra J.A. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm. Res. 11:1994;659-664.
161. Niemiec S.M., Ramachandran C., Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. Pharm. Res. 12:1995;1184-1188.
162. van Hal D., van Rensen A., de Vringer T., Junginger H., Bouwstra J. Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro. Stp Pharma Sci. 6:1996;72-78.
163. van den Bergh B.A.I., Salomons-de Vries I., Bouwstra J.A. Interactions between liposomes and human stratum corneum studied by freeze-substitution electron microscopy. Int. J. Pharm. 167:1998;57-67.
164. Agarwal R., Katare O.P., Vyas S.P. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int. J. Pharm. 228:2001;43-52.
165. Carafa M., Santucci E., Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int. J. Pharm. 231:2002;21-32.
166. Cevc G., Schätzlein A., Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release. 13:1995;3-16.
167. van Kuijk-Meuwissen M.E., Junginger H.E., Bouwstra J.A. Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study. Biochim. Biophys. Acta. 1371:1998;31-39.
168. Cevc G. Lipid suspensions on the skin. Permeation enhancement, vesicle penetration and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;257-388.
169. Jenning V., Gysler A., Schafer-Korting M., Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49:2000;211-218.
170. Pinto-Alphandary H., Andremont A., Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int. J. Antimicrob. Agents. 13:2000;155-168.
171. Kreilgraad M. Cutaneous Drug Delivery Potential of Microemulsion Vehicles - Application of a Pharmacokinetic Microdialysis Model to Assess Skin Penetration. 2000;194 Royal Danish School of Pharmacy, Kopenhagen.
172. J.A. Bouwstra, P.L. Honeywell-Nguyen, A. de Graaff, W. Groenink, H.E. Junginger, Elastic vesicles: drug transport and mechanisms of action. Proceedings of 5th Internatonal Conference Liposome Advances, London, 2001, p. 51.
173. van Kuijk-Meuwissen M.E., Mougin L., Junginger H.E., Bouwstra J.A. Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. J. Control. Release. 56:1998;189-196.
174. Schaetzlein A., Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138:1998;583-592.
175. O. Simonetti, J.A. Hoogstrate, W. Bialik, J.A. Kempenaar, A.H.G.J. Schrijvers, H.E. Boddé, M. Ponec, Visualization of diffusion pathways across the stratum corneum of native and in vitro reconstructed epidermis by confocal laser scanning microscopy, Arch. Dermatol. Res. 287 (1995) 465-473.
176. Cevc G., Blume G., Schätzlein A., Gebauer D., Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. 18:1996;349-378.
177. Paul A., Cevc G. Non-invasive administration of protein antigens. Epicutaneous immunization with the bovine serum albumin. Vaccine Res. 4:1995;145-164.
178. Cevc G., Blume G., Schätzlein A., Gebauer D., Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. 18:1996;349-378.
179. Allen T.M., Hansen C.B., Guo L.S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta. 1150:1993;9-16.
180. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta. 1514:2001;191-205.
181. H.M.H. Reinl, A.P. Dettmar, T.M. Bayerl, Time-resolved infrared ATR measurements of liposome transport kinetics in human keratinocyte cultures and skin reveal a dependence on liposome size and phase state, J. Invest. Dermatol. 105 (1995) 291-295.
182. Ogiso T., Nishioka S., Iwaki M. Dissociation of insulin oligomers and enhancement of percutaneous absorption of insulin. Biol. Pharm. Bull. 19:1996;1049-1054.
183. Guo J., Ping Q., Zhang L. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv. 7:2000;113-116.
184. Van den Bergh B.A.I., Bouwstra J.A., Junginger H.E., Wertz P.W. Elasticity of vesicles assessed by electron spin resonance, electron microscopy, and extrusion measurement. Int. J. Pharm. 217:2001;13-24.
185. D.A. Honeywell, P.L. Nguyen, H.E. Junginger, J.A. Bouwstra, Interactions between elastic and rigid vesicles with human skin in vivo and in vitro, Stratum Corneum III, Basel, CH, 2001, Conference Proceedings.
186. G. Cevc, A method for the improvement of transport across adaptable semi-permeable barriers, PCT/EP99/04659, 1999.
187. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers, Transfersomes® Clin. Pharmacokinet. 42:2003;461-474.
188. Lehmann T.K., Klede J.M., Ikoma A., Schmelz M., Rother M., von Wussow P. Expression of surrogate markers after transdermal delivery of IFN alpha in Transfersom® Int. J. Immunother. 18:2002;21-26.
189. S.I. Simões, H.C. Richardsen, M.B. Martins, M.E. Cruz, G. Cevc, Superoxide dismutase delivery through the narrow pores in skin models by flexible lipid aggregates, III Spanish-Portuguese Conference on Controlled Drug Delivery, Lisbon, Portugal, 1998.
190. Paul A., Cevc G. Noninvasive administrationof protein antigens: transdermal immunization with bovine serum albumin in Transfersomes® Vaccine Res. 4:1995;145-164.
191. Paul A., Cevc G., Bachhawat B.K. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, Transfersomes® Vaccine. 16:1998;188-195.
192. A. Chopra, G. Cevc, Non-invasive vaccination through the skin, 2000, EP 99 10 1479, 1476.
193. Michel C., Purmann T., Mentrup E., Seiller E., Kreuter J. Effect of liposomes on percutaneous penetration of lipophilic materials. Int. J. Pharm. 84:1992;93-105.
194. Foldvari M., Baca-Estrada M.E., He Z., Hu J., Attah-Poku S., King M. Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha. Biotechnol. Appl. Biochem. 30:1999;129-137.
195. Valenta C., Wanka M., Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J. Control. Release. 63:2000;165-173.
196. Valenta C., Nowak M., Hadgraft J. Influence of phloretin and 6-ketocholestanol on the permeation of progesterone through porcine skin. Int. J. Pharm. 217:2001;79-86.
197. Betz G., Nowbakht P., Imboden R., Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro. Int. J. Pharm. 228:2001;147-159.
198. Zülli F., Suter F. Preparation and properties of small nanoparticles for skin and hair care. SÖFW J. 123:1997;880-885.
199. Rhee Y.S., Choi J.G., Park E.S., Chi S.C. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228:2001;161-170.
200. Alexander M.Y., Akhurst R.J. Liposome-medicated gene transfer and expression via the skin. Hum. Mol. Genet. 4:1995;2279-2285.
201. Thiele B., Ghyczy M., Lunow C., Teichert H.M., Wolff H.H. Influence of phospholipid liposomes (PLL) on UVB-induced erythema formation. Arch. Dermatol. Res. 285:1993;428-431.
202. Touitou E., Schaffer F.L., Dayan N., Alhaique F., Riccieri F. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int. J. Pharm. 103:1994;131-136.
203. Schmid M.H., Korting H.C. Liposomes: a drug carrier system for topical treatment in dermatology. Crit. Rev. Ther. Drug Carrier Syst. 11:1994;97-118.
204. Korting H.C., Schäfer-Korting M. Topical liposome drugs. Benefit-Risk Ratio. 1999;333-357 CRC Press LLC, Boca Raton, FL.
205. H.M. Liao Yu, H.-Y., Triamcinolone permeation from different liposome formulations through rat skin in vitro, Int. J. Pharm. 127 (1995) 1-7.
206. Mezei M. Liposomes and the skin. Gregoridadis G., Florence A.T., Patel H. Liposomes in Drug Delivery. 1993;125-135 Harwood Academic Publishers, Switzerland.
207. Touitou E., Levischaffer F., Dayan N., Alhaique F., Riccieri F. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int. J. Pharm. 103:1994;131-136.
208. Yu W.H., Kashani-Sabet M., Liggitt D., Moore D., Heath T.D., Debs R.J. Topical gene delivery to murine skin. J. Invest. Dermatol. 112:1999;370-375.
209. Ghahary A., Tredget E.E., Shen Q., Kilani R.T., Scott P.G., Takeuchi M. Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig. Mol. Cell Biochem. 208:2000;129-137.
210. Cevc G., Blume G., Schätzlein A., Gebauer D., Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. 1:1995;349-378.
211. Cevc G., Blume G., Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Release. 45:1996;211-226.
212. Paul A., Cevc G., Bachhawat B.K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur. J. Immunol. 25:1995;3521-3524.
213. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta. 1514:2001;191-205.
214. Lehmann J., Nissen-Meyer S., Paul S., Klede M., Ikoma A., Schmelz M., Rother M., Cevc G. Dermal tolerance and safety of an IFN-alpha transfersome formulation. Ring J., Weidinger S., Darsow U. Skin and Environment - Perception and Protection. 2001;1031-1035 Monuzzi Editore, Bologna.
215. Fesq H., Gloeckner A., Abeck D., Ring J., Lehmann J., Rother M., Cevc G. Improved risk-benefit ratio for a triamcinolone acetonide Transfersome® formulation in comparison to a commercial triamcinolone acetonide formulation. Br. J. Dermatol. 149:2003;611-619.
216. M. Rother, S.R. Kopf, R. Doblhofer, G. Cevc, The characterisation of transdermal transport of non-diffusive systems may need different test models. Comparison of human skin diffusion cell, isolated perfused rabbit ears, in vivo microdialysis in rats and PK in pigs using IFN-a in Transfersomes®, EUFEPS World Conference on Drug Absorption and Drug Delivery, Copenhagen, Denmark, 2001, pp. 53-55.
217. Cevc G., Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes® Biochim. Biophys. Acta. 2003;156-164.
218. Cevc G G.D., Stieber J., Schatzlein A., Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta. 1368:1998;201-215.
219. F.-U. Flöther, R. Näff, R. Spycher, S. Delmenico, M. Corbo, Liposome-based topical vitamin D formulation, in US5834016, Cilag AG, CH (1998).
220. M.C. Russell, Treatment of equine laminitis, US 6,045,827, 1997.
221. J. Bouwstra, Phospholipid- and cholesterol-free aqueous composition for topical application to the skin, 1994, WOL 96/09812.
222. M. Foldvari, Biphasic lipid vesicles, US Patent No. 5,853,755, 1998.
223. E. Touitou, Compositions for applying active substances to or through the skin, USP 5716638, 1998.
224. Schätzlein A., Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138:1998;583-592.
225. Seddon J.M. Structure of the inverted hexagonal(H(2)) phase, and non-lamellar phase transitions of lipids. Biochim. Biophys. Acta. 1031:1990;1-69.
226. Perrett S., Golding M., Williams W.P. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J. Pharm. Pharmacol. 43:1991;154-161.
227. Kim M.K., Chung S.J., Lee M.H., Cho A.R., Shim C.K. Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J. Control. Release. 46:1997;243-251.
228. du Plessis J., Egbaria K., Ramachandran C., Weiner N. Topical delivery of liposomally encapsulated gamma-interferon. Antiviral Res. 18:1992;259-265.
229. Short S.M., Rubas W., Paasch B.D., Mrsny R.J. Transport of biologically active interferon-gamma across human skin in vitro. Pharm. Res. 12:1995;1140-1145.
230. Cevc G., Blume G., Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vitro. J. Control. Release. 45:1996;211-226.
231. Weiner N., Williams N., Birch G., Ramachandran C., Shipman C., Flynn G. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob. Agents Chemother. 33:1989;1217-1221.
232. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:(Suppl. 1):2002;131-155.